Sign Up for Bullseye Daily Alerts
Subscribe to our newsletter to get our newest articles instantly!
I’ve always been fascinated by space… I grew up on Dune, 2001: A Space Odyssey, and (pre-Disney) Star Wars. The prospect of humanity exploring the stars, deploying satellites, and potentially…
Buckle up, folks, because the biotech stock market as of March 26, 2025, is a jungle…
Amgen (AMGN) is the biotech jungle’s hulking gorilla, stomping at $283.50 (TipRanks) with a $100 billion+…
Nvidia (NVDA) is the electrifying frontman of the tech scene, rocking the AI and semiconductor stage…
If you're trading FOMC events or chasing fast market moves, X (formerly Twitter) is your real-time…
I’ve always been fascinated by space… I grew up on Dune, 2001:…
Retail investors crushed it in April 2025 — buying when hedge funds…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt…
Consumers Are Scared, and That Means — Opportunity! The headlines have been…
Retail investors crushed it in April 2025 — buying when hedge funds bailed and turning the…
Consumers Are Scared, and That Means — Opportunity! The headlines have been impossible to miss: In…
Hey Folks, Jeff Bishop here, Around 1:00 ET yesterday, stock traders felt the ground shift beneath…
BioNTech (BNTX) is the biotech jungle’s speedy cheetah, sprinting at $95.50 (TipRanks) with a $35 billion market cap as of…
Regeneron Pharmaceuticals (REGN) is the biotech jungle’s clever monkey, swinging at $730.30 (U.S. News) with a $103 billion market cap…
Vertex Pharmaceuticals (VRTX) is the biotech jungle’s roaring lion, lounging at $485.58 (StockAnalysis.com) with a market cap north of $125…
Sign in to your account